Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy
Clinical trial NCT05040932 · COMPLETED
Trial details
- NCT number
- NCT05040932
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2023-07-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.